Tactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Sells $55,536.60 in Stock

Tactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Elaine M. Birkemeyer sold 3,778 shares of the company’s stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.70, for a total transaction of $55,536.60. Following the transaction, the chief financial officer now owns 104,098 shares of the company’s stock, valued at approximately $1,530,240.60. The trade was a 3.50 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Tactile Systems Technology Stock Performance

Shares of TCMD opened at $14.52 on Thursday. The company has a 50-day simple moving average of $17.09 and a 200-day simple moving average of $15.72. The company has a quick ratio of 3.80, a current ratio of 4.36 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $342.45 million, a PE ratio of 20.74 and a beta of 1.20. Tactile Systems Technology, Inc. has a 52-week low of $11.12 and a 52-week high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.09. The firm had revenue of $85.59 million for the quarter, compared to analysts’ expectations of $85.39 million. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.37%. Equities research analysts predict that Tactile Systems Technology, Inc. will post 0.7 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on TCMD shares. StockNews.com downgraded shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 16th. B. Riley downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and cut their price target for the company from $23.00 to $18.00 in a report on Wednesday, February 19th. BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Finally, Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th.

Institutional Investors Weigh In On Tactile Systems Technology

A number of large investors have recently added to or reduced their stakes in TCMD. Creative Planning acquired a new stake in Tactile Systems Technology in the 3rd quarter valued at about $187,000. Arcadia Investment Management Corp MI acquired a new stake in Tactile Systems Technology in the 3rd quarter valued at about $29,000. Los Angeles Capital Management LLC grew its stake in Tactile Systems Technology by 36.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 135,796 shares of the company’s stock valued at $1,984,000 after acquiring an additional 36,409 shares during the last quarter. Victory Capital Management Inc. acquired a new stake in Tactile Systems Technology in the 3rd quarter valued at about $180,000. Finally, Royce & Associates LP grew its stake in Tactile Systems Technology by 2.5% in the 3rd quarter. Royce & Associates LP now owns 612,979 shares of the company’s stock valued at $8,956,000 after acquiring an additional 14,780 shares during the last quarter. 83.43% of the stock is owned by institutional investors and hedge funds.

About Tactile Systems Technology

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.